FOCIS 2009 - 2013: The 9th through 13th Annual Meetings of the Federation of Clin
FOCIS 2009 - 2013: The 9th through 13th Annual Meetings of the Federation of Clin
批准号:
8278695
负责人:
Abul K. Abbas
金额:
$2.0万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-06-09 至 2014-05-31
关键词:
Applied ResearchAreaAsthmaAutoimmune DiseasesAutoimmune ProcessAwardBacterial InfectionsBasic ScienceBiotechnologyCellsClinicalClinical ImmunologyCommunicable DiseasesComplexCritical PathwaysCritiquesDevelopmentDiagnosisDisciplineDiseaseDrug IndustryEducationEnsureEvolutionFeedbackFellowshipFosteringFunctional disorderGenerationsGenesGeneticGoalsGraft RejectionHIVHealthHost DefenseHumanHypersensitivityImmuneImmune systemImmunogeneticsImmunological DiagnosisImmunologyImmunotherapyIncubatorsIndividualInfectionInflammatoryInternationalInterventionKnowledgeLaboratoriesLearningLifeLinkMalignant NeoplasmsOralOrganPlayRegulationResearchResearch PersonnelRoleScienceScientific Advances and AccomplishmentsScientistServicesSocietiesStructureTechniquesTherapeuticTherapeutic InterventionTranslatingTranslationsTravelVaccinesVirusVirus DiseasesVisionVoiceWorkabstractingbasebench to bedsideclinical applicationclinical practicecostdemographicsimmune functionimmunoregulationimprovedinterdisciplinary approachinterestmedical specialtiesmeetingsmicrobialmultidisciplinarynovelnovel diagnosticsnovel therapeutic interventionpathogenpostersprogramspublic health relevancesuccesstranslational approach
中文摘要
项目概要/摘要
焦点 2009 - 焦点 2013
了解免疫系统的功能和调节对于许多疾病至关重要,包括
自身免疫性疾病、癌症、过敏/哮喘、传染病、免疫缺陷和移植
拒绝。为了快速利用这一领域的科学进步,需要克服两个主要障碍:首先,
将基本发现转化为临床和医学相关背景,第二,交流
免疫科学的相关发现通过多学科统一这些不同的疾病
突破传统临床界限的方法。 FOCIS,临床免疫学联合会
社团是为满足这些需求而存在的领先国际组织。链接超过20个
代表 40,000 名拥有这一共同愿景的专业人士的主要专业协会是一项服务,
确保通过免疫学改善人类健康的目标取得进展。
FOCIS 年会提供了一个科学论坛,促进了跨学科方法的发展,
了解和治疗基于免疫的疾病。免疫学领域的演变反映了
许多疾病的共同病理生理学,包括:自身免疫性疾病、癌症、过敏/哮喘、
传染病、免疫缺陷和移植排斥。虽然临床医生必须保持联系
针对与其自身专业相关的疾病,免疫学科学的最新进展
诊断和治疗这些不同的疾病是多学科的,并且跨越标准临床
边界。 FOCIS 年会的最终目标是让人们更好地了解
临床免疫学和新治疗方法的共同病理生理学基础
这些新的关系表明,包括生物制剂在治疗中的日益广泛使用。
FOCIS 年会为研究者和临床医生提供了一个理解和翻译的机会
来自各个不同领域的基础科学和临床应用的突破。
除了强调最好的科学之外,FOCIS 年会还是发展的孵化器
科学家和从业者等与相关代表一起会面
生物技术和制药业。每天包括海报和口头摘要演示
让年轻的研究人员有机会展示和批评他们的工作。 FOCIS 采取具体措施
关心年轻研究者的发展,并为他们提供旅行奖励,以补充他们的
参加会议的费用。
通过相互分享发现,代表们获得了研究和应用科学的新想法
他们不会在特定疾病或器官的会议上接触到这些学科。的
FOCIS 年会是新研究者了解不同转化的理想论坛
在临床实践中架起基础免疫学实验室桥梁的方法。
除了鼓励新研究者的参与之外,FOCIS 还认识到以下方面的重要性:
来自广泛人群的参与。尽一切努力纳入多元化的代表性
FOCIS 组委会和年会的科学计划。所有人的成功
FOCIS 之前的八次会议证明了这一努力。现在请求支持 2009-
2013 年 FOCIS 会议,特别是教育计划和旅行奖学金,将继续这一活动
宝贵的努力。
英文摘要
Project Summary/Abstract
FOCIS 2009 - FOCIS 2013
Understanding function and regulation of the immune system is critical for many diseases, including
autoimmune diseases, cancer, allergy/asthma, infectious diseases, immune deficiency, and transplant
rejection. To rapidly exploit scientific advances in this area, two major barriers need to be overcome: First,
the translation of basic findings into clinically and medically relevant contexts, and second, the exchange of
relevant findings in immunological sciences which unify these diverse diseases through multidisciplinary
approaches which cut across traditional clinical boundaries. FOCIS, the Federation of Clinical Immunology
Societies, is the leading international organization which exists to meet these needs. Linking more than 20
major professional societies representing 40,000 professionals with this common vision is a service that will
ensure progress towards the goal of improving human health through immunology.
The FOCIS Annual Meeting provides a scientific forum that fosters a cross-disciplinary approach required to
understand and treat immune-based diseases. The evolution of the immunology field is a reflection of the
shared pathophysiology of many diseases, including: autoimmune diseases, cancer, allergy/asthma,
infectious diseases, immune deficiency and transplant rejection. While clinicians necessarily remain linked
to diseases associated with their own specialty, the immunological sciences underlying recent advances in
diagnosing and treating these diverse diseases are multidisciplinary and cut across standard clinical
boundaries. The ultimate goal of the FOCIS annual meeting is to create a better understanding of the
shared pathophysiological underpinnings of clinical immunology and the new therapeutic approaches
suggested by these novel relationships, including the increasingly widespread use of biologics in therapy.
The FOCIS Annual Meeting offers investigators and clinicians an opportunity to understand and translate
breakthroughs in basic science and clinical applications from a variety of different fields.
In addition to highlighting the best science, the FOCIS Annual Meeting is an incubator for developing
scientists and practitioners alike to meet with one another along with representatives of relevant
biotechnology and pharmaceutical industry. Each day includes poster and oral abstract presentations to
give young investigators the chance to have their work presented and critiqued. FOCIS takes a specific
interest in the development of young investigators and provide travel awards to them to supplement their
costs to attend the meeting.
By sharing discoveries with one another, delegates acquire new ideas for research and applied science
from disciplines to which they would otherwise not be exposed at disease- or organ-specific meetings. The
FOCIS Annual Meeting is an ideal forum for new investigators to learn about the different translational
approaches that are bridging the basic immunology laboratories within clinical practice.
In addition to encouraging the participation of new investigators, FOCIS recognizes the importance of
participation from a wide range of demographics. Every effort is made to include a diverse representation
within the FOCIS Organizing Committee and the Annual Meeting's scientific program. The success of all
eight of the previous FOCIS meetings attests to this effort. Support is now requested to support the 2009-
2013 FOCIS meetings, specifically the educational programs and travel fellowships, which will continue this
valuable effort.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
FOCIS 2009 - 2013: The 9th through 13th Annual Meetings of the Federation of Clin
-
批准号:8078836
-
项目类别:
-
资助金额:$2.0万
-
财政年份:2009
-
负责人:Abul K. Abbas
-
依托单位:
Stability and Plasticity of Regulatory T Cells
-
批准号:7688823
-
项目类别:
-
资助金额:$19.73万
-
财政年份:2009
-
负责人:Abul K. Abbas
-
依托单位:
FOCIS 2009 - 2013: The 9th through 13th Annual Meetings of the Federation of Clin
-
批准号:8470530
-
项目类别:
-
资助金额:$2.0万
-
财政年份:2009
-
负责人:Abul K. Abbas
-
依托单位:
Interleukin-2 and autoimmune disease
-
批准号:7994862
-
项目类别:
-
资助金额:$37.86万
-
财政年份:2007
-
负责人:Abul K. Abbas
-
依托单位:
Interleukin-2 and autoimmune disease
-
批准号:8196707
-
项目类别:
-
资助金额:$37.86万
-
财政年份:2007
-
负责人:Abul K. Abbas
-
依托单位:
Interleukin-2 and autoimmune disease
-
批准号:7370244
-
项目类别:
-
资助金额:$38.55万
-
财政年份:2007
-
负责人:Abul K. Abbas
-
依托单位:
13th International Congress of Immunology
-
批准号:7333178
-
项目类别:
-
资助金额:$1.0万
-
财政年份:2007
-
负责人:Abul K. Abbas
-
依托单位:
Interleukin-2 and autoimmune disease
-
批准号:7534357
-
项目类别:
-
资助金额:$38.63万
-
财政年份:2007
-
负责人:Abul K. Abbas
-
依托单位:
Interleukin-2 and autoimmune disease
-
批准号:7740173
-
项目类别:
-
资助金额:$38.24万
-
财政年份:2007
-
负责人:Abul K. Abbas
-
依托单位:
Mechanisms of Peripheral CD4 T-cells tolerance
-
批准号:7215471
-
项目类别:
-
资助金额:$30.75万
-
财政年份:2006
-
负责人:Abul K. Abbas
-
依托单位:
Immunodeficiency and Autoimmunity
-
批准号:7176170
-
项目类别:
-
资助金额:$44.47万
-
财政年份:2005
-
负责人:Abul K. Abbas
-
依托单位:
Immunodefiency and Autoimmunity
-
批准号:7011236
-
项目类别:
-
资助金额:$36.98万
-
财政年份:2005
-
负责人:Abul K. Abbas
-
依托单位:
Immunodeficiency and Autoimmunity
-
批准号:6911877
-
项目类别:
-
资助金额:$37.88万
-
财政年份:2005
-
负责人:Abul K. Abbas
-
依托单位:
Immunodefiency and Autoimmunity
-
批准号:7270255
-
项目类别:
-
资助金额:$2.65万
-
财政年份:2005
-
负责人:Abul K. Abbas
-
依托单位:
Immunodeficiency and Autoimmunity
-
批准号:7346921
-
项目类别:
-
资助金额:$43.46万
-
财政年份:2005
-
负责人:Abul K. Abbas
-
依托单位:
Immunodeficiency and Autoimmunity
-
批准号:7560013
-
项目类别:
-
资助金额:$43.47万
-
财政年份:2005
-
负责人:Abul K. Abbas
-
依托单位:
MECHANISMS OF T CELL TOLERANCE VS AUTOIMMUNITY IN VIVO
-
批准号:6616873
-
项目类别:
-
资助金额:$23.07万
-
财政年份:2002
-
负责人:Abul K. Abbas
-
依托单位:
MEMORY T CELL DEVELOPMENT
-
批准号:6374228
-
项目类别:
-
资助金额:$25.81万
-
财政年份:2000
-
负责人:Abul K. Abbas
-
依托单位:
MEMORY T CELL DEVELOPMENT
-
批准号:6740217
-
项目类别:
-
资助金额:$25.81万
-
财政年份:2000
-
负责人:Abul K. Abbas
-
依托单位:
MEMORY T CELL DEVELOPMENT
-
批准号:6532789
-
项目类别:
-
资助金额:$23.23万
-
财政年份:2000
-
负责人:Abul K. Abbas
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: